Dr. Matthew Galsky discusses the FDA approval of Imfinzi and chemo before and after surgery for muscle-invasive bladder ...

D modeling for robotic prostatectomyCost comparison of checkpoint inhibitors in high-risk bladder cancerAI-generated prostate ...

Investigators compared oncologic outcomes among patients with tumors in the bladder only vs in the bladder neck/urethra.

Enfortumab vedotin is now available for patients who received prior platinum-containing chemotherapy and a PD-1/L1 inhibitor ...

"It has given me a new beginning - I feel like the me of 30 years ago," she said. "Since I was a child, I knew I was the ...

EXCLUSIVE: The sister of a man whose deadly bladder cancer only reared its head when it was tragically too late has revealed ...

The following is a summary of “Comparison of hyperthermic intravesical chemotherapy using pirarubicin and Bacillus ...

The following is a summary of “Cytokeratin 17 activates AKT signaling to induce epithelial-mesenchymal transition and promote bladder cancer progression,” published in the April 2025 issue of BMC ...

Antibody-drug conjugates combined with immunotherapy have redefined the standard of care for advanced bladder cancer, ...

Given a global shortage of bacillus Calmette-Guérin (BCG) treatment, it has been important to determine whether there are effective alternatives for intermediate-risk non-muscle-invasive bladder ...

It is well known that men are reluctant to see a doctor, especially a urologist. As a result, there is a risk that prostate ...